These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 3261034)
1. Altered natural killer cell activity in childhood acute non-lymphoid leukaemia. Augmented natural killer cell activity and cells expressing the Leu 7 and Leu 11b (CD 16) markers in the bone marrow of children in remission. Sørskaar D; Førre O; Tjønneland S; Lie SO Scand J Immunol; 1988 Jul; 28(1):11-7. PubMed ID: 3261034 [TBL] [Abstract][Full Text] [Related]
2. Increased natural killer cell activity and numbers of Leu-7 and Leu-11b (CD 16)-positive cells in bone marrow of children in remission from acute lymphoblastic leukaemia. Sørskaar D; Førre O; Lie SO Scand J Immunol; 1989 Jan; 29(1):65-72. PubMed ID: 2466327 [TBL] [Abstract][Full Text] [Related]
3. Natural killer cells in chronic leukemia. Function and markers. Sørskaar D; Førre O; Stavem P Int Arch Allergy Appl Immunol; 1988; 87(2):159-64. PubMed ID: 2973442 [TBL] [Abstract][Full Text] [Related]
4. Natural cytotoxicity in adult acute leukemia. Sørskaar D; Førre O; Albrechtsen D; Stavem P Int Arch Allergy Appl Immunol; 1988; 86(2):190-5. PubMed ID: 3292440 [TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of purified Leu 19+ cells from the peripheral blood of children with acute lymphocytic leukemia. Afify ZA; Abdel-Mageed A; Findley HW; Ragab AH Cancer; 1990 Aug; 66(3):469-73. PubMed ID: 1694716 [TBL] [Abstract][Full Text] [Related]
7. Natural killer cell activity of peripheral blood and bone marrow mononuclear cells from patients with childhood acute lymphoblastic leukemia. Sørskaar D; Lie SO; Førre O Acta Paediatr Scand; 1985 May; 74(3):433-7. PubMed ID: 3859177 [TBL] [Abstract][Full Text] [Related]
8. Decreased natural killer cell activity versus normal natural killer cell markers in mononuclear cells from patients with smouldering leukemia. Sørskaar D; Førre O; Albrechtsen D; Stavem P Scand J Haematol; 1986 Aug; 37(2):154-61. PubMed ID: 3764338 [TBL] [Abstract][Full Text] [Related]
9. A recycling defect as a characteristic of natural killer cells in childhood acute lymphoblastic leukemia. Yabuhara A; Kawai H Pediatr Res; 1990 Dec; 28(6):572-8. PubMed ID: 2284152 [TBL] [Abstract][Full Text] [Related]
10. Natural killer cells in the blood and bone marrow of the rhesus monkey. Gengozian N; Longley RE; Filler J; Good RA Cell Immunol; 1986 Aug; 101(1):24-38. PubMed ID: 3742605 [TBL] [Abstract][Full Text] [Related]
11. Natural killer cells in children with malignant solid tumors. Effect of recombinant interferon-alpha and interleukin-2 on natural killer cell function against tumor cell lines. Alvarado CS; Findley HW; Chan WC; Hnath RS; Abdel-Mageed A; Pais RC; Kutner MH; Ragab AH Cancer; 1989 Jan; 63(1):83-9. PubMed ID: 2783377 [TBL] [Abstract][Full Text] [Related]
12. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4. Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200 [TBL] [Abstract][Full Text] [Related]
13. The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia. Lowdell MW; Ray N; Craston R; Corbett T; Deane M; Prentice HG Bone Marrow Transplant; 1997 May; 19(9):891-7. PubMed ID: 9156262 [TBL] [Abstract][Full Text] [Related]
14. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children]. Pituch-Noworolska A Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422 [TBL] [Abstract][Full Text] [Related]
15. Natural killer cells in children with acute leukemia. The effect of interleukin-2. Mageed AA; Findley HW; Franco C; Singhapakdi S; Alvarado C; Chan WC; Ragab AH Cancer; 1987 Dec; 60(12):2913-8. PubMed ID: 3499970 [TBL] [Abstract][Full Text] [Related]
16. Depressed natural killer (NK) function in blood and marrow is related to the decrease in CD 11+ cells in acute leukemia. Morikawa K; Nakano A; Oseko F; Morikawa S Jpn J Med; 1989; 28(4):485-91. PubMed ID: 2572713 [TBL] [Abstract][Full Text] [Related]
17. Bone marrow and peripheral blood natural killer cell activity in lymphomas. Its response to IL-2. Caldera LH; Leon-Ponte M; Acquatella G; Bianco NE; Blanca I Clin Exp Immunol; 1992 Apr; 88(1):143-8. PubMed ID: 1373350 [TBL] [Abstract][Full Text] [Related]
18. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor. Chang WC; Hsiao MH; Pattengale PK Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400 [TBL] [Abstract][Full Text] [Related]
19. Depressed lymphokine-activated killer activity and analysis of the precursor cells in peripheral blood of patients with hepatocellular carcinoma. Shirai M; Watanabe S; Nishioka M Hepatogastroenterology; 1990 Oct; 37(5):465-8. PubMed ID: 2174825 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms accounting for the impaired natural-killer cell activity in refractory anaemia with excess of blasts. Eliopoulos GD; Coulocheri SA; Eliopoulos AG; Katrinakis G; Karkavitsas N; Kyriakou D; Vaiopoulos G; Foudoulakis A Eur J Haematol; 1992 May; 48(5):237-43. PubMed ID: 1379537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]